London & Partners


Capital named as leading city for life sciences


A report has named London the number one city in Europe and third globally for life sciences, behind Boston and New York, and ahead of Amsterdam, Munich, Paris, San Francisco and Singapore. T e Global Cities Comparison Report launched by MedCity


ahead of London Life Sciences Week, benchmarked London’s life sciences sector against other global cities across five key areas: research innovation, health research environment, talent ecosystem, investment environment and business environment. With the highest global ranking for its health research environment,


London stands out for its high concentration of clinics, rapid recruitment of participants in early-stage clinical trials and supportive regulatory system. T e UK capital has over 35 biomedical research centres and serves one of the world’s most diverse populations, with 8.9 million residents – 40% of whom identify with either Asian, Black, Mixed or other ethnic groups. T e combination of world-leading research clinicians, a diverse


trial population, integrated digital health systems, and a globally respected regulatory body makes London an attractive destination for health research and new medicine development.


In research innovation, London is a close second to Boston. T e


UK capital is home to three of the world’s top 15 universities for clinical and health sciences and has the highest number of Nobel Prize-winning scientists outside of New York and Boston. London’s high calibre of research and technical innovation is evident. T e city’s life sciences research community not only produces the highest volume of publications but also participates in the greatest number of international research collaborations outside of the US. When it comes to London’s business environment, the city ranks


second globally, just behind New York. With a thriving ecosystem of over 2,400 life sciences companies, the UK capital has become a prime destination for life sciences businesses, attracted by its international connectivity, commitment to sustainability, low operational risk, and access to high-quality talent at competitive labour costs. T is strong foundation enables London’s life sciences innovators


to fully leverage the power of AI. T e UK capital has more AI and data-focused life sciences companies than any other worldwide, collectively raising over £2.2bn in investment to date. Major fi rms like pharma giant GlaxoSmithKline (GSK) have established their largest AI teams in London. T e city is a global leader in AI talent, as well as home to leading AI research centres, including the Alan Turing Institute and Google’s DeepMind. T e Global Cities Comparison Report was released ahead of


London Life Sciences Week where hundreds of industry leaders, innovators, and investors gathered for a week of networking, deal- making and celebrating life sciences innovation.


ALL THINGS BUSINESS | 20


Page 1  |  Page 2  |  Page 3  |  Page 4  |  Page 5  |  Page 6  |  Page 7  |  Page 8  |  Page 9  |  Page 10  |  Page 11  |  Page 12  |  Page 13  |  Page 14  |  Page 15  |  Page 16  |  Page 17  |  Page 18  |  Page 19  |  Page 20  |  Page 21  |  Page 22  |  Page 23  |  Page 24  |  Page 25  |  Page 26  |  Page 27  |  Page 28  |  Page 29  |  Page 30  |  Page 31  |  Page 32